The University of Chicago Header Logo

Connection

Robert Naclerio to Adult

This is a "connection" page, showing publications Robert Naclerio has written about Adult.
Connection Strength

1.291
  1. A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge. Am J Rhinol Allergy. 2016 Jul; 30(4):269-73.
    View in: PubMed
    Score: 0.037
  2. Diagnostic algorithm for unilateral sinus disease: a 15-year retrospective review. Int Forum Allergy Rhinol. 2015 Jul; 5(7):590-6.
    View in: PubMed
    Score: 0.034
  3. Unilateral nasal allergic reactions increase bilateral sinus eosinophil infiltration. J Appl Physiol (1985). 2013 Nov 01; 115(9):1262-7.
    View in: PubMed
    Score: 0.030
  4. Effect of intranasal fluticasone furoate and intraocular olopatadine on nasal and ocular allergen-induced symptoms. Am J Rhinol Allergy. 2013 Jan; 27(1):48-53.
    View in: PubMed
    Score: 0.029
  5. Evidence of maxillary sinus inflammation in seasonal allergic rhinitis. Otolaryngol Head Neck Surg. 2012 Jun; 146(6):880-6.
    View in: PubMed
    Score: 0.027
  6. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011 Apr; 127(4):927-34.
    View in: PubMed
    Score: 0.026
  7. Recruitment factors which affect the outcome of a seasonal allergic rhinitis trial. Allergy Asthma Proc. 2011 Jan-Feb; 32(1):55-63.
    View in: PubMed
    Score: 0.025
  8. A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010 09; 48(3):318-24.
    View in: PubMed
    Score: 0.025
  9. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009 Jun; 123(6):1342-8.
    View in: PubMed
    Score: 0.023
  10. Is conjunctival allergen challenge a model of seasonal rhinoconjunctivitis? Allergy Asthma Proc. 2009 Mar-Apr; 30(2):212-3; author reply 213-4.
    View in: PubMed
    Score: 0.022
  11. Otolaryngology (urban) legend: the more programs to which you apply, the better the chances of matching. Arch Otolaryngol Head Neck Surg. 2008 Oct; 134(10):1038.
    View in: PubMed
    Score: 0.022
  12. Effect of changing airway pressure on the ability of the human nose to warm and humidify air. Ann Otol Rhinol Laryngol. 2008 Jul; 117(7):501-5.
    View in: PubMed
    Score: 0.021
  13. Serum 25-hydroxyvitamin D levels are lower in urban African American subjects with chronic rhinosinusitis. J Allergy Clin Immunol. 2008 Aug; 122(2):415-7.
    View in: PubMed
    Score: 0.021
  14. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008 May; 121(5):1126-1132.e7.
    View in: PubMed
    Score: 0.021
  15. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2008 Mar; 100(3):194-9.
    View in: PubMed
    Score: 0.021
  16. Elucidating the mechanism underlying the ocular symptoms associated with allergic rhinitis. Allergy Asthma Proc. 2008 Jan-Feb; 29(1):24-8.
    View in: PubMed
    Score: 0.021
  17. Familial aggregation of nasal conditioning capacity. J Appl Physiol (1985). 2007 Sep; 103(3):1078-81.
    View in: PubMed
    Score: 0.020
  18. Patient and physician perspectives on the attributes of nasal allergy medications. Allergy Asthma Proc. 2007 May-Jun; 28 Suppl 1:S11-7.
    View in: PubMed
    Score: 0.020
  19. Total IgE levels do not change 1 year after endoscopic sinus surgery in patients with chronic rhinosinusitis. Int Arch Allergy Immunol. 2006; 139(2):146-8.
    View in: PubMed
    Score: 0.018
  20. Alpha-adrenoreceptor blockade with phenoxybenzamine does not affect the ability of the nose to condition air. J Appl Physiol (1985). 2005 Jul; 99(1):128-33.
    View in: PubMed
    Score: 0.017
  21. Increased nasal airflow with budesonide compared with desloratadine during the allergy season. Arch Otolaryngol Head Neck Surg. 2005 Mar; 131(3):223-8.
    View in: PubMed
    Score: 0.017
  22. Treatment of nasal inflammation decreases the ability of subjects with asthma to condition inspired air. Am J Respir Crit Care Med. 2004 Oct 15; 170(8):863-9.
    View in: PubMed
    Score: 0.016
  23. Elevation of the nasal mucosal surface temperature after warming of the feet occurs via a neural reflex. Acta Otolaryngol. 2003 Jun; 123(5):627-36.
    View in: PubMed
    Score: 0.015
  24. A comparison of nasal clearance after treatment of perennial allergic rhinitis with budesonide and mometasone. Otolaryngol Head Neck Surg. 2003 Feb; 128(2):220-7.
    View in: PubMed
    Score: 0.015
  25. Pharmacokinetic Evidence of Steady and Sustained Drug Release from Long-Acting Implantable Corticosteroid Matrices for Chronic Rhinosinusitis. Am J Rhinol Allergy. 2022 Nov; 36(6):733-740.
    View in: PubMed
    Score: 0.014
  26. Supine position decreases the ability of the nose to warm and humidify air. J Appl Physiol (1985). 2001 Dec; 91(6):2459-65.
    View in: PubMed
    Score: 0.013
  27. Hot, humid air increases cellular influx during the late-phase response to nasal challenge with antigen. Clin Exp Allergy. 2001 Dec; 31(12):1913-22.
    View in: PubMed
    Score: 0.013
  28. The nasal passage of subjects with asthma has a decreased ability to warm and humidify inspired air. Am J Respir Crit Care Med. 2001 Nov 01; 164(9):1640-6.
    View in: PubMed
    Score: 0.013
  29. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: A systematic review for the EAACI guidelines. Allergy. 2021 08; 76(8):2337-2353.
    View in: PubMed
    Score: 0.013
  30. Absence of nasal mucosal atrophy with fluticasone aqueous nasal spray. Arch Otolaryngol Head Neck Surg. 2001 Feb; 127(2):193-9.
    View in: PubMed
    Score: 0.013
  31. Elevation of nasal mucosal temperature increases the ability of the nose to warm and humidify air. Am J Rhinol. 2001 Jan-Feb; 15(1):41-5.
    View in: PubMed
    Score: 0.013
  32. Natural and induced allergic responses increase the ability of the nose to warm and humidify air. J Allergy Clin Immunol. 2000 Dec; 106(6):1045-52.
    View in: PubMed
    Score: 0.013
  33. Unusual presentation of a rare nasal tumor. Otolaryngol Head Neck Surg. 2000 Dec; 123(6):746-7.
    View in: PubMed
    Score: 0.013
  34. Ipratropium bromide increases the ability of the nose to warm and humidify air. Am J Respir Crit Care Med. 2000 Sep; 162(3 Pt 1):1031-7.
    View in: PubMed
    Score: 0.012
  35. Hot, humid air partially inhibits the nasal response to allergen provocation. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):749-54.
    View in: PubMed
    Score: 0.012
  36. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000 Apr; 105(4):732-8.
    View in: PubMed
    Score: 0.012
  37. Dupilumab reduces opacification across all sinuses and related symptoms in patients with CRSwNP. Rhinology. 2020 Feb 01; 58(1):10-17.
    View in: PubMed
    Score: 0.012
  38. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020 01; 75(1):148-157.
    View in: PubMed
    Score: 0.012
  39. Comparison of the response to histamine challenge of the nose and the maxillary sinus: effect of loratadine. J Appl Physiol (1985). 1999 Sep; 87(3):1038-47.
    View in: PubMed
    Score: 0.012
  40. Warming of feet elevates nasal mucosal surface temperature and reduces the early response to nasal challenge with allergen. J Allergy Clin Immunol. 1999 Aug; 104(2 Pt 1):285-93.
    View in: PubMed
    Score: 0.011
  41. A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol (1985). 1999 Jul; 87(1):400-6.
    View in: PubMed
    Score: 0.011
  42. Dupilumab improves patient-reported outcomes in patients with chronic rhinosinusitis with nasal polyps and comorbid asthma. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2447-2449.e2.
    View in: PubMed
    Score: 0.011
  43. Relationship between histamine and physiological changes during the early response to nasal antigen provocation. J Appl Physiol (1985). 1999 Feb; 86(2):659-68.
    View in: PubMed
    Score: 0.011
  44. Optimizing treatment options. Clin Exp Allergy. 1998 Dec; 28 Suppl 6:54-9.
    View in: PubMed
    Score: 0.011
  45. Intranasal beclomethasone reduces allergen-induced symptoms and superficial mucosal eosinophilia without affecting submucosal inflammation. Am J Respir Crit Care Med. 1998 Mar; 157(3 Pt 1):899-906.
    View in: PubMed
    Score: 0.010
  46. Total IgE serum levels correlate with sinus mucosal thickness on computerized tomography scans. J Allergy Clin Immunol. 1997 Oct; 100(4):563-8.
    View in: PubMed
    Score: 0.010
  47. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997 Sep; 100(3):293-300.
    View in: PubMed
    Score: 0.010
  48. Bilateral increases in histamine after unilateral nasal allergen challenge. Am J Respir Crit Care Med. 1997 Feb; 155(2):426-31.
    View in: PubMed
    Score: 0.010
  49. Ragweed allergic rhinitis and the paranasal sinuses. A computed tomographic study. Arch Otolaryngol Head Neck Surg. 1997 Feb; 123(2):193-6.
    View in: PubMed
    Score: 0.010
  50. Treatment with hot, humid air reduces the nasal response to allergen challenge. J Allergy Clin Immunol. 1997 Jan; 99(1 Pt 1):77-86.
    View in: PubMed
    Score: 0.010
  51. Effects of loratadine and terfenadine on the induced nasal allergic reaction. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):309-16.
    View in: PubMed
    Score: 0.009
  52. Duration of action of intranasal atropine on methacholine-induced nasal secretions. Arch Otolaryngol Head Neck Surg. 1996 Mar; 122(3):321-3.
    View in: PubMed
    Score: 0.009
  53. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016 Feb 02; 315(5):469-79.
    View in: PubMed
    Score: 0.009
  54. Lack of effect of hot, humid air on response to nasal challenge with histamine. Ann Otol Rhinol Laryngol. 1996 Feb; 105(2):146-54.
    View in: PubMed
    Score: 0.009
  55. Eosinophilia in chronic childhood sinusitis. Arch Otolaryngol Head Neck Surg. 1995 Dec; 121(12):1396-402.
    View in: PubMed
    Score: 0.009
  56. Cold dry air-induced rhinitis: effect of inhalation and exhalation through the nose. J Appl Physiol (1985). 1995 Aug; 79(2):467-71.
    View in: PubMed
    Score: 0.009
  57. Inhibition of the response to nasal provocation with bradykinin by HOE-140: efficacy and duration of action. Can J Physiol Pharmacol. 1995 Jul; 73(7):820-6.
    View in: PubMed
    Score: 0.009
  58. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995 Jan; 151(1):136-44.
    View in: PubMed
    Score: 0.008
  59. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014 Jul-Aug; 28(4):281-6.
    View in: PubMed
    Score: 0.008
  60. Physiologic responses and histamine release after nasal antigen challenge. Effect of atropine. Am J Respir Crit Care Med. 1994 Jun; 149(6):1457-65.
    View in: PubMed
    Score: 0.008
  61. Effect of prednisone on nasal symptoms and peripheral blood T-cell function in chronic rhinosinusitis. Int Forum Allergy Rhinol. 2014 Aug; 4(8):609-16.
    View in: PubMed
    Score: 0.008
  62. The effect of terfenadine on unilateral nasal challenge with allergen. J Allergy Clin Immunol. 1994 Mar; 93(3):594-605.
    View in: PubMed
    Score: 0.008
  63. Onset and duration of inhibition of ipratropium bromide nasal spray on methacholine-induced nasal secretions. Clin Exp Allergy. 1994 Mar; 24(3):288-90.
    View in: PubMed
    Score: 0.008
  64. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine. Am J Respir Crit Care Med. 1994 Mar; 149(3 Pt 1):660-6.
    View in: PubMed
    Score: 0.008
  65. A pilot study of the effects of intranasal budesonide delivered by NasoNebĀ® on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014 Jan; 4(1):43-8.
    View in: PubMed
    Score: 0.008
  66. Intranasal steroids inhibit seasonal increases in ragweed-specific immunoglobulin E antibodies. J Allergy Clin Immunol. 1993 Nov; 92(5):717-21.
    View in: PubMed
    Score: 0.008
  67. Demonstration of bilateral cholinergic secretory response after unilateral nasal cold, dry air challenge. Rhinology. 1993 Sep; 31(3):97-100.
    View in: PubMed
    Score: 0.008
  68. Advertisements impact the physiological efficacy of a branded drug. Proc Natl Acad Sci U S A. 2013 Aug 06; 110(32):12931-5.
    View in: PubMed
    Score: 0.008
  69. Comparison of the secretory response of the nasal mucosa to methacholine and histamine. J Appl Physiol (1985). 1993 Jun; 74(6):2661-71.
    View in: PubMed
    Score: 0.007
  70. Blood loss during endoscopic sinus surgery with propofol or sevoflurane: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2013 May; 139(5):510-4.
    View in: PubMed
    Score: 0.007
  71. Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys. Allergy Asthma Proc. 2012 Sep-Oct; 33 Suppl 1:S113-41.
    View in: PubMed
    Score: 0.007
  72. Peripheral blood and tissue T regulatory cells in chronic rhinosinusitis. Am J Rhinol Allergy. 2012 Sep-Oct; 26(5):371-9.
    View in: PubMed
    Score: 0.007
  73. Local application of atropine attenuates the upper airway reaction to cold, dry air. Am Rev Respir Dis. 1992 Aug; 146(2):340-6.
    View in: PubMed
    Score: 0.007
  74. The nasal response to histamine challenge: effect of the pollen season and immunotherapy. J Allergy Clin Immunol. 1992 Jul; 90(1):85-91.
    View in: PubMed
    Score: 0.007
  75. Ipratropium bromide (Atrovent nasal spray) reduces the nasal response to methacholine. J Allergy Clin Immunol. 1992 Jun; 89(6):1065-75.
    View in: PubMed
    Score: 0.007
  76. Evaluation of a bedtime dose of a combination antihistamine/analgesic/decongestant product on antigen challenge the next morning. Laryngoscope. 1992 Mar; 102(3):330-4.
    View in: PubMed
    Score: 0.007
  77. The effect of azelastine on the early allergic response. Clin Exp Allergy. 1992 Feb; 22(2):289-95.
    View in: PubMed
    Score: 0.007
  78. Antigen-provoked increase in histamine reactivity. Observations on mechanisms. Am Rev Respir Dis. 1991 Sep; 144(3 Pt 1):642-8.
    View in: PubMed
    Score: 0.007
  79. Steroid-induced reduction of histamine release does not alter the clinical nasal response to cold, dry air. Am Rev Respir Dis. 1991 Apr; 143(4 Pt 1):761-5.
    View in: PubMed
    Score: 0.006
  80. Localized antigen challenge of the nasal mucosa. Arch Otolaryngol Head Neck Surg. 1990 Dec; 116(12):1407-10.
    View in: PubMed
    Score: 0.006
  81. Relationship between the early, late, and rechallenge reaction to nasal challenge with antigen: observations on the role of inflammatory mediators and cells. J Allergy Clin Immunol. 1990 Dec; 86(6 Pt 1):851-61.
    View in: PubMed
    Score: 0.006
  82. Ketotifen reduces sneezing but not histamine release following nasal challenge with antigen. Clin Exp Allergy. 1990 Nov; 20(6):701-5.
    View in: PubMed
    Score: 0.006
  83. An integrated analysis of the efficacy of fluticasone furoate nasal spray on individual nasal and ocular symptoms of seasonal allergic rhinitis. Allergy Asthma Proc. 2010 Nov-Dec; 31(6):483-92.
    View in: PubMed
    Score: 0.006
  84. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010 Jul-Aug; 24(4):286-90.
    View in: PubMed
    Score: 0.006
  85. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):155-61.
    View in: PubMed
    Score: 0.006
  86. Studies on the relationships between sensitivity to cold, dry air, hyperosmolal solutions, and histamine in the adult nose. Am Rev Respir Dis. 1990 Jun; 141(6):1428-33.
    View in: PubMed
    Score: 0.006
  87. The effect of a leukotriene antagonist on the early response to antigen. Otolaryngol Head Neck Surg. 1990 Mar; 102(3):219-24.
    View in: PubMed
    Score: 0.006
  88. The congestion quantifier five-item test for nasal congestion: refinement of the congestion quantifier seven-item test. Am J Rhinol Allergy. 2010 Jan-Feb; 24(1):34-8.
    View in: PubMed
    Score: 0.006
  89. In vivo and in vitro effects of antihistamines on mast cell mediator release: a potentially important property in the treatment of allergic disease. Ann Allergy. 1989 Nov; 63(5):465-9.
    View in: PubMed
    Score: 0.006
  90. Diagnosis and management of chronic rhinosinusitis in adults. Postgrad Med. 2009 Nov; 121(6):121-39.
    View in: PubMed
    Score: 0.006
  91. Criteria to screen for chronic sinonasal disease. Chest. 2009 Nov; 136(5):1324-1332.
    View in: PubMed
    Score: 0.006
  92. A genomewide screen for chronic rhinosinusitis genes identifies a locus on chromosome 7q. Laryngoscope. 2008 Nov; 118(11):2067-72.
    View in: PubMed
    Score: 0.005
  93. Nasal provocation with bradykinin induces symptoms of rhinitis and a sore throat. Am Rev Respir Dis. 1988 Mar; 137(3):613-6.
    View in: PubMed
    Score: 0.005
  94. Is histamine responsible for the symptoms of rhinovirus colds? A look at the inflammatory mediators following infection. Pediatr Infect Dis J. 1988 Mar; 7(3):218-22.
    View in: PubMed
    Score: 0.005
  95. A genome-wide screen for hyposmia susceptibility Loci. Chem Senses. 2008 Apr; 33(4):319-29.
    View in: PubMed
    Score: 0.005
  96. Kinins are generated during experimental rhinovirus colds. J Infect Dis. 1988 Jan; 157(1):133-42.
    View in: PubMed
    Score: 0.005
  97. Development and validation of the Congestion Quantifier seven-item test (CQ7): a screening tool for nasal congestion. Value Health. 2007 Nov-Dec; 10(6):457-65.
    View in: PubMed
    Score: 0.005
  98. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987 Jun 11; 316(24):1506-10.
    View in: PubMed
    Score: 0.005
  99. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007 Jun; 119(6):1430-7.
    View in: PubMed
    Score: 0.005
  100. The effect of a topical tricyclic antihistamine on the response of the nasal mucosa to challenge with cold, dry air and histamine. J Allergy Clin Immunol. 1987 Apr; 79(4):599-604.
    View in: PubMed
    Score: 0.005
  101. Arachidonic acid metabolites during nasal challenge. Arch Otolaryngol Head Neck Surg. 1987 Feb; 113(2):179-83.
    View in: PubMed
    Score: 0.005
  102. Epithelial shedding is associated with nasal reactions to cold, dry air. J Allergy Clin Immunol. 2006 Jun; 117(6):1351-8.
    View in: PubMed
    Score: 0.005
  103. Inflammatory mediators in nasal secretions during induced rhinitis. Clin Allergy. 1986 Mar; 16(2):101-10.
    View in: PubMed
    Score: 0.005
  104. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006 Feb; 132(2):164-72.
    View in: PubMed
    Score: 0.004
  105. Theophylline reduces the response to nasal challenge with antigen. Am J Med. 1985 Dec 20; 79(6A):43-7.
    View in: PubMed
    Score: 0.004
  106. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med. 1985 Jul 11; 313(2):65-70.
    View in: PubMed
    Score: 0.004
  107. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004 Jan; 92(1):73-9.
    View in: PubMed
    Score: 0.004
  108. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1983 Oct; 128(4):597-602.
    View in: PubMed
    Score: 0.004
  109. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003 May; 129(5):557-62.
    View in: PubMed
    Score: 0.004
  110. Effects of fexofenadine on the early response to nasal allergen challenge. Ann Allergy Asthma Immunol. 2002 Dec; 89(6):578-84.
    View in: PubMed
    Score: 0.004
  111. Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002 Jan; 112(1):47-52.
    View in: PubMed
    Score: 0.003
  112. A retrospective analysis of the intact canal wall tympanoplasty with mastoidectomy. Am J Otol. 1981 Apr; 2(4):315-7.
    View in: PubMed
    Score: 0.003
  113. Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg. 2000 Jun; 126(6):741-8.
    View in: PubMed
    Score: 0.003
  114. Decreased neuropeptide release may play a role in the pathogenesis of nasal polyps. Otolaryngol Head Neck Surg. 1999 Nov; 121(5):585-90.
    View in: PubMed
    Score: 0.003
  115. Comparison of nasal mucosal responsiveness to neuronal stimulation in non-allergic and allergic rhinitis: effects of capsaicin nasal challenge. Clin Exp Allergy. 1998 Jan; 28(1):92-100.
    View in: PubMed
    Score: 0.003
  116. Low dose clemastine inhibits sneezing and rhinorrhea during the early nasal allergic reaction. Ann Allergy Asthma Immunol. 1997 Mar; 78(3):307-12.
    View in: PubMed
    Score: 0.002
  117. Unilateral nasal allergen challenge leads to bilateral release of prostaglandin D2. Clin Exp Allergy. 1996 Apr; 26(4):371-8.
    View in: PubMed
    Score: 0.002
  118. Nasal challenge with allergen upregulates the local expression of vascular endothelial adhesion molecules. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1006-16.
    View in: PubMed
    Score: 0.002
  119. The human nasal response to capsaicin. J Allergy Clin Immunol. 1994 Dec; 94(6 Pt 1):1035-45.
    View in: PubMed
    Score: 0.002
  120. Characterization of phospholipase A2 from human nasal lavage. Am J Respir Cell Mol Biol. 1994 Jul; 11(1):108-13.
    View in: PubMed
    Score: 0.002
  121. Reflex activation of nasal secretion by unilateral inhalation of cold dry air. Am Rev Respir Dis. 1993 Dec; 148(6 Pt 1):1616-22.
    View in: PubMed
    Score: 0.002
  122. Tryptase and histamine as markers to evaluate mast cell activation during the responses to nasal challenge with allergen, cold, dry air, and hyperosmolar solutions. J Allergy Clin Immunol. 1992 Jun; 89(6):1098-110.
    View in: PubMed
    Score: 0.002
  123. Histamine-containing cells obtained from the nose hours after antigen challenge have functional and phenotypic characteristics of basophils. J Immunol. 1992 Apr 01; 148(7):2223-8.
    View in: PubMed
    Score: 0.002
  124. A competitive kinin receptor antagonist, [DArg0, Hyp3, DPhe7]-bradykinin, does not affect the response to nasal provocation with bradykinin. Br J Clin Pharmacol. 1991 Mar; 31(3):287-94.
    View in: PubMed
    Score: 0.002
  125. A randomized controlled trial of glucocorticoid prophylaxis against experimental rhinovirus infection. J Infect Dis. 1990 Nov; 162(5):1173-7.
    View in: PubMed
    Score: 0.002
  126. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis. 1990 Sep; 142(3):594-601.
    View in: PubMed
    Score: 0.002
  127. Comparison of the in-vivo and in-vitro response to ragweed immunotherapy in children and adults with ragweed-induced rhinitis. Clin Exp Allergy. 1990 Sep; 20(5):491-500.
    View in: PubMed
    Score: 0.002
  128. Ragweed IgE and IgG4 antibody in nasal secretions during immunotherapy. Clin Exp Allergy. 1990 Sep; 20(5):571-9.
    View in: PubMed
    Score: 0.002
  129. Effects of a single-dose pretreatment with captopril on the immediate response to nasal challenge with allergen. Int Arch Allergy Appl Immunol. 1990; 93(2-3):165-70.
    View in: PubMed
    Score: 0.001
  130. Kinins are generated in nasal secretions during natural rhinovirus colds. J Infect Dis. 1990 Jan; 161(1):120-3.
    View in: PubMed
    Score: 0.001
  131. Attenuation of allergen sensitivity early in the course of ragweed immunotherapy. J Allergy Clin Immunol. 1989 Sep; 84(3):390-9.
    View in: PubMed
    Score: 0.001
  132. Responses to ragweed-pollen nasal challenge before and after immunotherapy. J Allergy Clin Immunol. 1989 Aug; 84(2):197-205.
    View in: PubMed
    Score: 0.001
  133. Leukotriene B4 as a mediator of early and late reactions to antigen in humans: the effect of systemic glucocorticoid treatment in vivo. J Allergy Clin Immunol. 1989 Mar; 83(3):634-42.
    View in: PubMed
    Score: 0.001
  134. In vivo release of inflammatory mediators by hyperosmolar solutions. Am Rev Respir Dis. 1988 Mar; 137(3):606-12.
    View in: PubMed
    Score: 0.001
  135. The effect of a histamine synthesis inhibitor on the immediate nasal allergic reaction. Allergy. 1987 Oct; 42(7):496-501.
    View in: PubMed
    Score: 0.001
  136. Endoscopic middle meatal antrostomy: theory, technique, and patency. Laryngoscope. 1987 Aug; 97(8 Pt 3 Suppl 43):1-9.
    View in: PubMed
    Score: 0.001
  137. Kinin metabolism in human nasal secretions during experimentally induced allergic rhinitis. J Immunol. 1987 Jan 15; 138(2):428-34.
    View in: PubMed
    Score: 0.001
  138. Concentrations of glandular kallikrein in human nasal secretions increase during experimentally induced allergic rhinitis. J Immunol. 1986 Aug 15; 137(4):1323-8.
    View in: PubMed
    Score: 0.001
  139. Plasma kallikrein during experimentally induced allergic rhinitis: role in kinin formation and contribution to TAME-esterase activity in nasal secretions. J Immunol. 1986 Aug 01; 137(3):977-82.
    View in: PubMed
    Score: 0.001
  140. Demonstration of inhibition of mediator release from human mast cells by azatadine base. In vivo and in vitro evaluation. JAMA. 1986 Jan 10; 255(2):225-9.
    View in: PubMed
    Score: 0.001
  141. Nasal challenge with ragweed pollen in hay fever patients. Effect of immunotherapy. J Clin Invest. 1985 Dec; 76(6):2247-53.
    View in: PubMed
    Score: 0.001
  142. Nasal challenge with cold, dry air results in release of inflammatory mediators. Possible mast cell involvement. J Clin Invest. 1985 Oct; 76(4):1375-81.
    View in: PubMed
    Score: 0.001
  143. Influx of kininogens into nasal secretions after antigen challenge of allergic individuals. J Clin Invest. 1985 Jul; 76(1):191-7.
    View in: PubMed
    Score: 0.001
  144. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N Engl J Med. 1984 Jun 21; 310(25):1626-30.
    View in: PubMed
    Score: 0.001
  145. Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen. J Clin Invest. 1983 Nov; 72(5):1678-85.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.